Is a complete LFCR research report available?

No complete published report is available for Lifecore Biomedical, Inc. (LFCR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Lifecore Biomedical, Inc. (LFCR)

NASDAQ: LFCR · USD

$6.50

+0.06 (+0.9%)· Recorded snapshot

Market cap	246M
Revenue (ttm)	129.5M
Net income (ttm)	-34.5M
EPS (ttm)	-$0.93
Shares out	37.9M
Volume	328,421
Beta	0.98

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 129.5M
Net income (ttm): -34.5M
EPS (ttm): -$0.93
Market cap: 246M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0001005286
Company name	Lifecore Biomedical, Inc.
Country	United States
Country code	US
CUSIP number	514766104
Earnings date	2026-11-09
Earnings time	amc
Employees	382
Employees change	-24
Employees growth	-5.91%
Enterprise value	$372.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1986
In index	RUSSELL2000
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
Is SPAC	No
ISIN number	US5147661046
Last 10-K release date	2025-08-07
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$246M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$6.50
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	LFCR
U.S. state	Minnesota
Website	https://www.lifecore.com

Metric

Value

Amount currency

USD

CIK code

0001005286

Company name

Lifecore Biomedical, Inc.

Country

United States

Country code

CUSIP number

514766104

Earnings date

2026-11-09

Earnings time

amc

Employees

382

Employees change

-24

Employees growth

-5.91%

Enterprise value

$372.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1986

In index

RUSSELL2000

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

Yes

Is SPAC

ISIN number

US5147661046

Last 10-K release date

2025-08-07

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$246M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$6.50

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

LFCR

U.S. state

Minnesota

Website

https://www.lifecore.com

Metric	Value
Earnings yield	-14.24%
EV/EBITDA	45.22x
EV/FCF	59.82x
EV/Sales	2.88x
FCF / EV yield	1.67%
FCF yield	2.53%
Forward EV/Sales	2.96x
Forward P/S	1.96x
Industry forward P/E	13.86x
Industry P/E	173.47x
P/(OCF - SBC) ratio	86.65x
P/B ratio	7.23x
P/FCF ratio	39.56x
P/OCF ratio	19.61x
P/S ratio	1.9x
Price/EBITDA ratio	29.9x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-14.24%

EV/EBITDA

45.22x

EV/FCF

59.82x

EV/Sales

2.88x

FCF / EV yield

1.67%

FCF yield

2.53%

Forward EV/Sales

2.96x

Forward P/S

1.96x

Industry forward P/E

13.86x

Industry P/E

173.47x

P/(OCF - SBC) ratio

86.65x

P/B ratio

7.23x

P/FCF ratio

39.56x

P/OCF ratio

19.61x

P/S ratio

1.9x

Price/EBITDA ratio

29.9x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-0.97%
EBITDA margin	6.37%
FCF margin	4.81%
Gross margin	31.37%
Operating margin	-0.97%
Pretax margin	-23.34%
Profit margin	-23.78%
Profit per employee	$-90,323
Revenue per employee	$338,913
ROCE	-0.6%
ROIC	-0.76%
ROIC (5Y)	-4.63%
SBC / revenue	7.51%
Tax / revenue	0.45%

Metric

Value

EBIT margin

-0.97%

EBITDA margin

6.37%

FCF margin

4.81%

Gross margin

31.37%

Operating margin

-0.97%

Pretax margin

-23.34%

Profit margin

-23.78%

Profit per employee

$-90,323

Revenue per employee

$338,913

ROCE

-0.6%

ROIC

-0.76%

ROIC (5Y)

-4.63%

SBC / revenue

7.51%

Tax / revenue

0.45%

Metric	Value
EPS growth years	0
Gross profit growth	-8.76%
Gross profit growth (Q)	-13.64%
Gross profit growth 3Y	5.47%
Gross profit growth 5Y	-11.64%
Net income growth years	0
OCF growth	68.24%
OCF growth 10Y	-4.75%
OCF growth 5Y	18.32%
Operating income growth (Q)	-11.45%
Revenue growth	0.8%
Revenue growth (Q)	-6.25%
Revenue growth (QoQ)	47.32%
Revenue growth 10Y	-13.32%
Revenue growth 3Y	11.51%
Revenue growth 5Y	-26.1%
Revenue growth years	2

Metric

Value

EPS growth years

Gross profit growth

-8.76%

Gross profit growth (Q)

-13.64%

Gross profit growth 3Y

5.47%

Gross profit growth 5Y

-11.64%

Net income growth years

OCF growth

68.24%

OCF growth 10Y

-4.75%

OCF growth 5Y

18.32%

Operating income growth (Q)

-11.45%

Revenue growth

0.8%

Revenue growth (Q)

-6.25%

Revenue growth (QoQ)

47.32%

Revenue growth 10Y

-13.32%

Revenue growth 3Y

11.51%

Revenue growth 5Y

-26.1%

Revenue growth years

Metric	Value
Capital expenditures	$-6.3M
Depreciation and amortization	$9.5M
EBIT	$-1.3M
EBITDA	$8.2M
EPS	$-0.93
FCF per share	$0.16
Financing cash flow	$-7.6M
Free cash flow	$6.2M
Free cash flow minus SBC	$-3.5M
Gross profit	$40.6M
Income taxes	$577,714
Investing cash flow	$10.8M
Net borrowing	$-4.3M
Net cash flow	$15.8M
Net income	$-34.5M
Operating cash flow minus SBC	$2.8M
Operating income	$-1.3M
Revenue	$129.5M
Stock-based compensation	$9.7M

Metric

Value

Capital expenditures

$-6.3M

Depreciation and amortization

$9.5M

EBIT

$-1.3M

EBITDA

$8.2M

EPS

$-0.93

FCF per share

$0.16

Financing cash flow

$-7.6M

Free cash flow

$6.2M

Free cash flow minus SBC

$-3.5M

Gross profit

$40.6M

Income taxes

$577,714

Investing cash flow

$10.8M

Net borrowing

$-4.3M

Net cash flow

$15.8M

Net income

$-34.5M

Operating cash flow minus SBC

$2.8M

Operating income

$-1.3M

Revenue

$129.5M

Stock-based compensation

$9.7M

Metric	Value
Altman Z-Score	0.29
Book value per share	$-0.38
Debt / EBITDA	16.83
Debt / equity	4.22
Debt / FCF	23.07
Goodwill	$13.9M
Interest coverage	-0.05
Long-term assets	$148.5M
Long-term liabilities	$176.5M
Net cash (debt)	$-126.3M
Net cash / market cap	-51.24%
Net debt / EBITDA	15.32
Net debt / equity	3.71
Net debt / FCF	20.27
Piotroski F-Score	3
Property, plant and equipment	$123.7M
Shareholders' equity	$34.1M
Tangible book value	$-32.3M
Tangible book value per share	$-0.86
Total assets	$232.2M
Total cash	$17.5M
Total debt	$143.7M
Total liabilities	$198.1M
WACC	11.59%

Metric

Value

Altman Z-Score

0.29

Book value per share

$-0.38

Debt / EBITDA

16.83

Debt / equity

4.22

Debt / FCF

23.07

Goodwill

$13.9M

Interest coverage

-0.05

Long-term assets

$148.5M

Long-term liabilities

$176.5M

Net cash (debt)

$-126.3M

Net cash / market cap

-51.24%

Net debt / EBITDA

15.32

Net debt / equity

3.71

Net debt / FCF

20.27

Piotroski F-Score

Property, plant and equipment

$123.7M

Shareholders' equity

$34.1M

Tangible book value

$-32.3M

Tangible book value per share

$-0.86

Total assets

$232.2M

Total cash

$17.5M

Total debt

$143.7M

Total liabilities

$198.1M

WACC

11.59%

Metric	Value
Current assets	$83.7M
Current liabilities	$21.6M
Current ratio	3.49
Net working capital	$42.6M
Quick ratio	2.18
Working capital	$58.7M

Metric

Value

Current assets

$83.7M

Current liabilities

$21.6M

Current ratio

3.49

Net working capital

$42.6M

Quick ratio

2.18

Working capital

$58.7M

Metric	Value
Buyback yield / dilution	-1.63%
Dividend yield	0%
Shareholder yield	-1.63%

Metric

Value

Buyback yield / dilution

-1.63%

Dividend yield

Shareholder yield

-1.63%

Metric	Value
10Y price change	-51.13%
10Y return CAGR	-6.91%
10Y total return	-51.13%
150-day SMA	$5.02
15Y price change	-0.31%
15Y return CAGR	-0.02%
15Y total return	-0.31%
1D price change	0.93%
1M price change	54.76%
1M total return	54.76%
1W price change	2.04%
1W total return	2.04%
1Y price change	-3.42%
1Y return CAGR	-3.42%
1Y total return	-3.42%
20-day SMA	$6.44
200-day SMA	$5.52
20Y price change	-32.5%
20Y return CAGR	-1.95%
20Y total return	-32.5%
3M price change	49.77%
3M total return	49.77%
3Y price change	-7.54%
3Y return CAGR	-2.58%
3Y total return	-7.54%
50-day SMA	$5.34
50-day SMA vs 200-day SMA	50under200
52-week high	$8.98
52-week high date	2026-01-27
52-week low	$3.63
52-week low date	2026-03-31
5Y price change	-30.48%
5Y return CAGR	-7.01%
5Y total return	-30.48%
6M price change	27.95%
6M total return	27.95%
All-time high	$20.75
All-time high date	1996-05-22
All-time low	$1.51
All-time low date	2002-09-13
Average true range (ATR)	$0.12
Average volume	570.3K
Beta (1Y)	2.25
Beta (2Y)	1.85
Beta (5Y)	0.98
Change from 52-week high	-27.62%
Change from 52-week low	79.31%
Change from all-time high	-68.67%
Change from all-time low	330.46%
Change from open	1.09%
Day's gap	-0.16%
Dollar volume	$2.1M
High price	$6.51
Low price	$6.43
Monthly RSI	50.56
Open price	$6.43
Position in 52-week range	87.5%
Previous close	$6.44
Price vs 150-day SMA	29.53%
Price vs 20-day SMA	0.98%
Price vs 200-day SMA	17.69%
Price vs 50-day SMA	21.65%
Relative volume	0.58
RSI	74.1
Sharpe ratio	0.28
Sharpe ratio (3Y)	0.27
Sharpe ratio (5Y)	0.3
Sortino ratio	0.58
Sortino ratio (3Y)	0.48
Sortino ratio (5Y)	0.55
Volume	328.4K
Weekly RSI	60.39
YTD price change	-20.54%
YTD total return	-20.54%

Metric

Value

10Y price change

-51.13%

10Y return CAGR

-6.91%

10Y total return

-51.13%

150-day SMA

$5.02

15Y price change

-0.31%

15Y return CAGR

-0.02%

15Y total return

-0.31%

1D price change

0.93%

1M price change

54.76%

1M total return

54.76%

1W price change

2.04%

1W total return

2.04%

1Y price change

-3.42%

1Y return CAGR

-3.42%

1Y total return

-3.42%

20-day SMA

$6.44

200-day SMA

$5.52

20Y price change

-32.5%

20Y return CAGR

-1.95%

20Y total return

-32.5%

3M price change

49.77%

3M total return

49.77%

3Y price change

-7.54%

3Y return CAGR

-2.58%

3Y total return

-7.54%

50-day SMA

$5.34

50-day SMA vs 200-day SMA

50under200

52-week high

$8.98

52-week high date

2026-01-27

52-week low

$3.63

52-week low date

2026-03-31

5Y price change

-30.48%

5Y return CAGR

-7.01%

5Y total return

-30.48%

6M price change

27.95%

6M total return

27.95%

All-time high

$20.75

All-time high date

1996-05-22

All-time low

$1.51

All-time low date

2002-09-13

Average true range (ATR)

$0.12

Average volume

570.3K

Beta (1Y)

2.25

Beta (2Y)

1.85

Beta (5Y)

0.98

Change from 52-week high

-27.62%

Change from 52-week low

79.31%

Change from all-time high

-68.67%

Change from all-time low

330.46%

Change from open

1.09%

Day's gap

-0.16%

Dollar volume

$2.1M

High price

$6.51

Low price

$6.43

Monthly RSI

50.56

Open price

$6.43

Position in 52-week range

87.5%

Previous close

$6.44

Price vs 150-day SMA

29.53%

Price vs 20-day SMA

0.98%

Price vs 200-day SMA

17.69%

Price vs 50-day SMA

21.65%

Relative volume

0.58

RSI

74.1

Sharpe ratio

0.28

Sharpe ratio (3Y)

0.27

Sharpe ratio (5Y)

0.3

Sortino ratio

0.58

Sortino ratio (3Y)

0.48

Sortino ratio (5Y)

0.55

Volume

328.4K

Weekly RSI

60.39

YTD price change

-20.54%

YTD total return

-20.54%

Metric	Value
Float	19.3M
Float percentage	51.1%
Shares change (QoQ)	0.26%
Shares change (YoY)	1.63%
Shares held by insiders	3.75%
Shares held by institutions	27.35%
Shares outstanding	37.9M
Short % of float	12.8%
Short % of shares	6.54%
Short ratio	6.3 days

Metric

Value

Float

19.3M

Float percentage

51.1%

Shares change (QoQ)

0.26%

Shares change (YoY)

1.63%

Shares held by insiders

3.75%

Shares held by institutions

27.35%

Shares outstanding

37.9M

Short % of float

12.8%

Short % of shares

6.54%

Short ratio

6.3 days

Lifecore Biomedical, Inc. (LFCR)

Price

Financial snapshot

Fair-value bridge

Latest news · LFCR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LFCR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LFCR

Frequently asked questions